Ola Kleveland

THE EFFECTS OF MYOCARDIAL INFARCTION RECOVERY AND ANTI-INFLAMMATORY DRUG ON LDL COMPOSITION AND ATHEROGENIC PROPERTIES IN NSTEMI PATIENTS

Alina Iakubovskaia, Thor Ueland, L. Gullestad, Kaspar Broch et autres

Effect of Interleukin-6 Receptor Inhibition by Tocilizumab on Platelet Activation and Markers of Thrombus Formation: A Substudy of the ASSAIL-MI Trial

Thor Ueland, Tuva B. Dahl, Annika E. Michelsen, Ola Kleveland et autres

no, us (code pays fourni par la source)

Balloon Lithotripsy Added to Conventional Preparation Before Stent Implantation in Severely Calcified Coronary Lesions

Andreas Torp Kristensen, Evald Høj Christiansen, Niels Ramsing Holm, Henning Kelbæk et autres

dk, no, be, ee (code pays fourni par la source)

The effects of interleukin-6-receptor inhibition on monocytes in STEMI: a substudy of the ASSAIL-MI trial

Camilla Huse, Sarah Louise Murphy, Kuan Yang, Nora Reka Balzer et autres

no, de, us (code pays fourni par la source)

The N-6 methyladenosine dynamics in STEMI and the effect of IL-6 inhibition - a hypothesis generating sub-study of the ASSAIL-MI trial

Tuva B. Dahl, Ana Quiles‐Jiménez, Kaspar Broch, Anne Kristine Anstensrud et autres

no, us (code pays fourni par la source)

Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCI

Sindre Woxholt, Thor Ueland, Pål Aukrust, Anne Kristine Anstensrud et autres

no (code pays fourni par la source)

Circular RNA Profile in Atherosclerotic Disease: Regulation during ST-Elevated Myocardial Infarction

Fredric A. Holme, Camilla Huse, Xiang Yi Kong, Kaspar Broch et autres

no, us (code pays fourni par la source)

Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on Atherosclerosis

Savvina Prapiadou, Luka Živković, Barbara Thorand, Marc J. George et autres

us, gr, it, de, gb, nl, no (code pays fourni par la source)

Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumab

Sindre Woxholt, Thor Ueland, Pål Aukrust, Anne Kristine Anstensrud et autres

no (code pays fourni par la source)

Proteogenomic integration reveals CXCL10 as a potentially downstream causal mediator for IL-6 signaling on atherosclerosis

Savvina Prapiadou, Luka Živković, Barbara Thorand, Marc J. George et autres

us, gr, de, gb, nl, no (code pays fourni par la source)

Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial

Camilla Huse, Anne Kristine Anstensrud, Annika E. Michelsen, Thor Ueland et autres

no (code pays fourni par la source)

Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction

Ragnhild Helseth, Ola Kleveland, Thor Ueland, Rune Wiseth et autres

no (code pays fourni par la source)